J. Mauro David's most recent trade in Recursion Pharmaceuticals Inc - Ordinary Shares - Class A was a trade of 4,187 Class A Common Stock done at an average price of $6.2 . Disclosure was reported to the exchange on Nov. 15, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Recursion Pharma Inc (Class A) | David J. Mauro | Chief Medical Officer | 15 Nov 2024 | 4,187 | 225,429 | - | 6.2 | 25,855 | Class A Common Stock | |
| Recursion Pharma Inc (Class A) | David J. Mauro | Chief Medical Officer | 15 Aug 2024 | 14,146 | 229,616 | - | 6.7 | 94,637 | Class A Common Stock | |
| Recursion Pharma Inc (Class A) | David J. Mauro | Chief Medical Officer | 15 May 2024 | 867 | 243,762 | - | 10.0 | 8,679 | Class A Common Stock | |
| Recursion Pharma Inc (Class A) | Mauro J. David | Chief Medical Officer | 09 Feb 2024 | 99,537 | 99,537 | - | - | Stock Option (RIght to Buy) | ||
| Recursion Pharma Inc (Class A) | J. Mauro David | Chief Medical Officer | 09 Feb 2024 | 49,768 | 246,521 | - | 0 | Class A Common Stock | ||
| Recursion Pharma Inc (Class A) | Mauro David J. | Chief Medical Officer | 09 Feb 2024 | 6,040 | 196,753 | - | 0 | Class A Common Stock | ||
| Recursion Pharma Inc (Class A) | J. David Mauro | Chief Medical Officer | 09 Feb 2024 | 1,892 | 244,629 | - | 10.1 | 19,090 | Class A Common Stock | |
| Recursion Pharma Inc (Class A) | David J. Mauro | Chief Medical Officer | 01 Jun 2023 | 381,426 | 381,426 | - | - | Stock Option (Right to Buy) | ||
| Recursion Pharma Inc (Class A) | David J. Mauro | Chief Medical Officer | 01 Jun 2023 | 190,713 | 190,713 | - | 0 | Class A Common Stock | ||
| Prelude Therapeutics Inc | David J. Mauro | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Oct 2021 | 15,000 | 137,610 | - | - | Employee Stock Option (Right to Buy) | |
| Prelude Therapeutics Inc | David J. Mauro | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.89 per share. | 05 Oct 2021 | 15,000 | 15,000 | - | 1.9 | 28,350 | Common Stock |
| Prelude Therapeutics Inc | David J. Mauro | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 31.30 per share. | 05 Oct 2021 | 7,803 | 1,289 | - | 31.3 | 244,257 | Common Stock |
| Prelude Therapeutics Inc | David J. Mauro | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 30.26 per share. | 05 Oct 2021 | 5,908 | 9,092 | - | 30.3 | 178,762 | Common Stock |
| Prelude Therapeutics Inc | David J. Mauro | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 32.06 per share. | 05 Oct 2021 | 1,289 | 0 | - | 32.1 | 41,330 | Common Stock |
| Prelude Therapeutics Inc | David J. Mauro | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Sep 2021 | 15,000 | 167,610 | - | - | Employee Stock Option (Right to Buy) | |
| Prelude Therapeutics Inc | David J. Mauro | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.89 per share. | 07 Sep 2021 | 15,000 | 15,000 | - | 1.9 | 28,350 | Common Stock |
| Prelude Therapeutics Inc | David J. Mauro | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 35.91 per share. | 07 Sep 2021 | 7,487 | 7,513 | - | 35.9 | 268,867 | Common Stock |
| Prelude Therapeutics Inc | David J. Mauro | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 37.79 per share. | 07 Sep 2021 | 4,640 | 0 | - | 37.8 | 175,334 | Common Stock |
| Prelude Therapeutics Inc | David J. Mauro | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 36.92 per share. | 07 Sep 2021 | 2,873 | 4,640 | - | 36.9 | 106,081 | Common Stock |
| Prelude Therapeutics Inc | David J. Mauro | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.89 per share. | 05 Aug 2021 | 15,000 | 15,000 | - | 1.9 | 28,350 | Common Stock |
| Prelude Therapeutics Inc | David J. Mauro | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Aug 2021 | 15,000 | 167,610 | - | - | Employee Stock Option (Right to Buy) | |
| Prelude Therapeutics Inc | David J. Mauro | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 32.15 per share. | 05 Aug 2021 | 6,721 | 100 | - | 32.1 | 216,051 | Common Stock |
| Prelude Therapeutics Inc | David J. Mauro | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 29.93 per share. | 05 Aug 2021 | 6,116 | 8,884 | - | 29.9 | 183,070 | Common Stock |
| Prelude Therapeutics Inc | David J. Mauro | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 31.03 per share. | 05 Aug 2021 | 2,063 | 6,821 | - | 31.0 | 64,010 | Common Stock |
| Prelude Therapeutics Inc | David J. Mauro | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 32.63 per share. | 05 Aug 2021 | 100 | 0 | - | 32.6 | 3,263 | Common Stock |